Parp inhibitors in ovarian cancer

Podcast 2022034
Download attendance certificate
e-ESO podcast channel
Listen on Spotify
Listen on Apple
Listen on Google

Questions:

  1. How does parp inhibitors act?
  2.   What are the predictive biomarkers for the response to parp inhibitors?
  3. Is PARP inhibitor recommended for recurrent Ovarian Cancer?
  4. What about the front line setting?
  5. Are there settings where a PARPinhibitor in combination with other targeted therapy are recommended?
Expert
Katia Roque Perez'
Katia Roque Perez
Instituto Nacional de Enfermedades Neoplasicas
Lima, Peru
29
Sep 2022
Download attendance certificate
e-ESO podcast channel
Listen on Spotify
Listen on Apple
Listen on Google
Related e-Sessions:
ESCO logo
ESCO is the College of the European School of Oncology for ESO students offering a structured educational pathway to enhance their oncology careers.
Ulm university
Ulm university
The e-ESO e-Sessions are part of the Master-Online Study Program Advanced Oncology of Ulm University
www.uni-ulm.de
The mastermind winners of
e-Session 660
  1. Reda Mohamed Husseen
  2. Marina Puchinskaya
  3. Zacharoula Sidiropoulou
ESO & OncoAlert
e-Eso Onco alert
Oncology education together via social media
facebook eso twitter eso instagram eso